Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Healthtrust
Medtronic
Cerilliant
Queensland Health
Citi
Express Scripts
Daiichi Sankyo
Cipla
McKinsey

Generated: February 25, 2018

DrugPatentWatch Database Preview

MEXILETINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Mexiletine Hydrochloride patents expire, and when can generic versions of Mexiletine Hydrochloride launch?

Mexiletine Hydrochloride is a drug marketed by Idt Australia Ltd, Teva, and Watson Labs. and is included in four NDAs.

The generic ingredient in MEXILETINE HYDROCHLORIDE is mexiletine hydrochloride. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the mexiletine hydrochloride profile page.
Drug patent expirations by year for MEXILETINE HYDROCHLORIDE
Pharmacology for MEXILETINE HYDROCHLORIDE
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for MEXILETINE HYDROCHLORIDE

US Patents and Regulatory Information for MEXILETINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Idt Australia Ltd MEXILETINE HYDROCHLORIDE mexiletine hydrochloride CAPSULE;ORAL 074450-001 May 16, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs MEXILETINE HYDROCHLORIDE mexiletine hydrochloride CAPSULE;ORAL 074711-001 Feb 26, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva MEXILETINE HYDROCHLORIDE mexiletine hydrochloride CAPSULE;ORAL 074377-001 May 16, 1995 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs MEXILETINE HYDROCHLORIDE mexiletine hydrochloride CAPSULE;ORAL 074865-003 Apr 13, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs MEXILETINE HYDROCHLORIDE mexiletine hydrochloride CAPSULE;ORAL 074865-001 Apr 13, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Idt Australia Ltd MEXILETINE HYDROCHLORIDE mexiletine hydrochloride CAPSULE;ORAL 074450-002 May 16, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Idt Australia Ltd MEXILETINE HYDROCHLORIDE mexiletine hydrochloride CAPSULE;ORAL 074450-003 May 16, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva MEXILETINE HYDROCHLORIDE mexiletine hydrochloride CAPSULE;ORAL 074377-003 May 16, 1995 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva MEXILETINE HYDROCHLORIDE mexiletine hydrochloride CAPSULE;ORAL 074377-002 May 16, 1995 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs MEXILETINE HYDROCHLORIDE mexiletine hydrochloride CAPSULE;ORAL 074865-002 Apr 13, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
US Department of Justice
Covington
Cerilliant
UBS
Citi
Chubb
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot